News & Media

• 19 May
  Cubist Achieves Top Biotech Ranking in Globe 100 List
  Number Six Overall Ranking Reinforces Employee Dedication to Addressing Unmet Need in Acute Medical Care
  Sunday May. 19th 2013
• 7 May
  FDA Grants Fast Track Designation for Cubist’s Late-Stage Antibiotic Candidate
  Fast Track Status Provided for Ceftolozane/Tazobactam in HABP/VABP and cUTI
  Tuesday May. 7th 2013
• 18 Apr
  Cubist Reports First Quarter 2013 Financial Results
  Thursday Apr. 18th 2013

• View All News